Find uplifting stories about heroes, innovations, and solutions
6761 results for "hepatitis treatment"
After years without any approved therapies, adults living with chronic hepatitis delta virus now have hope with the FDA's approval of Hepcludex, the first treatment for one of the most severe forms of viral hepatitis. This breakthrough fills a critical gap for nearly 200,000 Americans who face rapid progression to serious liver complications.
A groundbreaking combination therapy has left nearly 9 in 10 hepatitis D patients with no detectable virus after two years of treatment. The results could transform care for a disease that often leads to liver failure within five years.
An experimental medicine called bepirovirsen achieved functional cures in nearly 20% of chronic hepatitis B patients during clinical trials, a massive leap from current treatments that cure only 1% to 3%. For a disease killing 1 million people annually, this breakthrough could transform millions of lives.
A medication already being tested for hepatitis C shows promising results against hepatitis E, a deadly virus that kills 70,000 people yearly and has no approved treatment. Scientists discovered bemnifosbuvir stops the virus from replicating without harming healthy cells.
A new treatment for one of the deadliest forms of viral hepatitis just got approved in China, offering hope to 12 million people worldwide who had almost no options. The drug, developed entirely in China from discovery to delivery, blocks both hepatitis B and D viruses from entering liver cells.
A groundbreaking hepatitis D treatment just won approval in China, offering hope to 12 million people worldwide living with one of the most severe forms of viral hepatitis. The drug represents a rare full-journey innovation, from basic science discovery to market-ready medicine, all developed domestically.
A groundbreaking hepatitis B treatment is helping one in five patients stop therapy entirely while keeping the deadly liver virus undetectable. After decades of searching, researchers may have found the path to a functional cure for a disease that kills 1.1 million people yearly.
A groundbreaking hepatitis B treatment has achieved what was once thought impossible: completely clearing the virus from patients' bodies. One in five participants in recent trials are now virus-free, offering hope to 296 million people worldwide living with chronic hepatitis B.
A groundbreaking treatment has achieved functional cures in one-fifth of chronic hepatitis B patients, offering hope for a disease that affects 296 million people worldwide. The weekly injection made the virus undetectable even after treatment stopped.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
Australian researchers proved a simple fingerstick test detects hepatitis B as accurately as lab tests, delivering results in just one hour instead of weeks. The breakthrough could bring lifesaving treatment to 254 million people worldwide who lack access to testing.
A groundbreaking hepatitis B treatment is letting patients stop therapy while keeping the deadly liver virus undetectable. The experimental drug achieved a "functional cure" in 20% of trial participants, a breakthrough decades in the making.
For the first time, a new treatment called bepirovirsen has achieved functional cure in 1 in 5 hepatitis B patients, compared to nearly zero with current therapies. This breakthrough could free millions from lifelong daily medication.
A team of scientists across five countries just received $24 million to pursue something 300 million people are waiting for: a cure for hepatitis B. The five-year project brings together researchers from Brazil, India, Senegal, Uganda, and the United States to turn laboratory discoveries into real treatments.
A breakthrough medication called bepirovirsen has functionally cured 20% of chronic hepatitis B patients within one year, marking the first major treatment advance in decades. The FDA is expected to decide on approval this October.
An experimental treatment by GSK achieved functional cures for nearly 20% of hepatitis B patients in major clinical trials, a massive leap from the 1-3% success rate of current medications. The breakthrough offers hope for millions living with a virus that kills a million people annually.
New World Health Organization data shows hepatitis C deaths have fallen 12% globally since 2015, with childhood hepatitis B infections down to just 0.6%. Countries like Egypt, Georgia, and Rwanda are proving that eliminating this deadly disease is possible with the right commitment and tools.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
Showing 20 of 6761